BJMO - volume 7, issue 2, may 2013
K. Vandecasteele MD, PhD, G. De Meerleer MD, PhD
The need for an efficient, fast technique to irradiate large concave targets lead to the introduction of intensity-modulated arc therapy in the multimodality treatment of pelvic gynaecological tumours. Postoperatively irradiated cervical and endometrial cancer patients benefit by reduced toxicity rates. In locally advanced cervical cancer the use of intensity-modulated arc therapy with a simultaneously integrated boost allows for a safe hysterectomy, resulting in promising control and survival rates. In chemotherapy-resistant ovarian cancer patients with peritoneal carcinomatosis, the use of intensity-modulated arc therapy facilitates a safe whole abdominopelvic irradiation, one of the few effective solutions for patients with bowel obstruction. Continuing efforts should be made to further decrease toxicity and increase response rates and survival in the multimodality treatment of pelvic gynaecological tumours.
(BELG J MED ONCOL 2013;7(2):53–56)
Read more
Top
To provide the best experiences, we and our partners use technologies like cookies to store and/or access device information. Consenting to these technologies will allow us and our partners to process personal data such as browsing behavior or unique IDs on this site and show (non-) personalized ads. Not consenting or withdrawing consent, may adversely affect certain features and functions.
Click below to consent to the above or make granular choices. Your choices will be applied to this site only. You can change your settings at any time, including withdrawing your consent, by using the toggles on the Cookie Policy, or by clicking on the manage consent button at the bottom of the screen.
